REGENXBIO Inc.’s Post

View organization page for REGENXBIO Inc., graphic

31,928 followers

1mo

We are pleased to announce that Curran Simpson has been appointed as REGENXBIO's next President and CEO. Our co-founder, Kenneth Mills, will remain on the Board of Directors, with an expanded role as Chairman. As we advance our pivotal stage clinical trials and approach commercialization, Curran’s extensive leadership in launching commercial products will spearhead an exciting new chapter for us. Since co-founding REGENXBIO in 2009, Ken has transformed the landscape of AAV gene therapy, and we are grateful for his vision and leadership. Read the full press release to learn more about Curran and this transition: https://lnkd.in/eNs4Skws

135 Comments

Srinivas Pai Raikar

Senior Director Business Development @ IQVIA | Fostering meaningful connections, driving growth

'Embrace the future by leading it today' is what reflects Curran Simpson moving into crucial role. Congratulations to Curran Simpson. Curran, with 35 years operational, commercial industry experience, is best equipped to pioneer the advance of pivotal stage clinical trials. 9 years of experience together, Curran will be a perfect foil to Kenneth Mills, the visionary founder leader. It is passing the torch to light the way forward. New vision, new victory for REGENXBIO Inc..

Tim Barabe

1mo

Congrats! Are you in DC still? If so, I’d love to get together, as I have a Board in Gaithersburg.

Darren Nelson 🚀 (We're hiring)

Innovative Leadership in Talent Solutions: Founder & CEO of Recruits Lab & BioJobs Lab, Driving Organizational Success through Cutting-Edge Recruitment Strategies.

Congratulations to Curran Simpson on being appointed as REGENXBIO Inc.'s new President and CEO! Looking forward to seeing the advancements and innovations under his leadership as the company approaches commercialization. Kudos to Kenneth Mills for his transformative work in AAV gene therapy. Exciting times ahead! #Leadership #GeneTherapy #RecruitsLab #BioJobsLab

Anthony MoragneEl

Sr. Planner at Catalent Pharma

1mo

Congratulations Curran well deserved

Mike O'Mara

Chief Operating Officer at Cellipont Bioservices

Congrats

Lisa Sykes-Winstead MBA, MSc, CQA

Site Quality Head - Senior Director - Cell and Gene Therapy - Problem Solver- Gene Therapy Product Approval Leader - Inspection Readiness

1mo

Congratulations

David Moore

Western Regional Rep. / Remote Field Engineer at Eastern Rivers Inc.

1mo

I am honored to say I was there in the beginning of Curran’s career at Genencor Inc. We all could see how bright his future was going to be!

Steven Walfish

1mo

Congrats. Next beer at DTC on me.

1 Reaction

Marguerite McDonald Davis

Senior Clinical Data Analyst, Foresite Capital

Great news, always a pleasure working with you. Congratulations!

Mauricio Almaraz

Supply Chain Logistics Professional, Father, Husband and man of God.

1mo

Congratulations 🎉🍾!!

See more comments

To view or add a comment, sign in

More Relevant Posts

REGENXBIO Inc.

31,928 followers
5d
Report this post
Did you know that June 14th was World Blood Donor Day? Recently, REGENXBIO partnered with the American Red Cross to host our second annual blood drive! These blood drives have the power to save lives and make a real impact on patients in need, a mission close to our hearts. Inspired to donate? Find a local blood drive here: https://lnkd.in/ebwyUut
Like Comment
To view or add a comment, sign in
REGENXBIO Inc.

31,928 followers
1w
Report this post
Happy Independence Day! Wishing you a safe and celebratory holiday.
Like Comment
To view or add a comment, sign in
REGENXBIO Inc.

31,928 followers
1w
Report this post
It was great attending Parent Project Muscular Dystrophy’s (PPMD) 30th Annual Conference last week in Orlando to connect and catch up with families, researchers, providers, and fellow industry colleagues. Dr. Naz Dastgir, Clinical Development Lead for our Duchenne program, shared an update on our RGX-202 program and participated in a panel discussion about clinical trials and the development pathway in Duchenne. Congratulations Pat Furlong and PPMD for hosting a great event!
1 Comment
Like Comment
To view or add a comment, sign in
REGENXBIO Inc.

31,928 followers
2w
Report this post
This Pride month, we’re celebrating LGBTQIA+ scientists in STEM. Today we highlight Jemma Redmond, an intersex person whose innovation in 3D bioprinting revolutionized medical technology. Learn more about Jemma and other inspiring scientists here: https://lnkd.in/dtzcYFp
Like Comment
To view or add a comment, sign in
REGENXBIO Inc.

31,928 followers
2w
Report this post
We’re heading to Orlando this week to join the Duchenne community in celebrating three decades of progress, community and resilience at PPMD’s 30th Annual Conference in Orlando, Florida! Thank you to Pat Furlong and the team at PPMD for your important work to support Duchenne families!

Parent Project Muscular Dystrophy

3,593 followers
2w

REGENXBIO Inc. has announced it initiated enrollment in a new cohort of patients ages 1-3 in its Phase I/II AFFINITY DUCHENNE® trial, and indicated that the company has confirmed an end-of-Phase II meeting is scheduled with the FDA at the end of July. REGENXBIO will be participating in PPMD’s 30th Annual Conference in Orlando, Florida during the “Research Row: Gene Therapy – Current and Evolving Landscape” session on Friday, June 28. If you haven't already registered to attend PPMD's 30th Annual Conference, register to attend virtually! https://lnkd.in/eV8Csijh

REGENXBIO Announces Expansion of AFFINITY DUCHENNE® Trial to Include New Cohort of Younger Patients

https://www.parentprojectmd.org

2 Comments
Like Comment
To view or add a comment, sign in
REGENXBIO Inc.

31,928 followers
2w
Report this post
REGENXBIO announces expansion of AFFINITY DUCHENNE® trial to include a new cohort of younger patients. Learn more: https://lnkd.in/enTeuAAi
1 Comment
Like Comment
To view or add a comment, sign in
REGENXBIO Inc.

31,928 followers
3w
Report this post
Today, REGENXBIO recognizes Juneteenth, also known as Freedom Day or Emancipation Day. This holiday commemorates the announcement of the abolition of slavery in Texas on June 19, 1865, two years after the Emancipation Proclamation was signed. It signifies the moment when the last enslaved African Americans learned of their freedom. On this day, we celebrate freedom, unity, and resilience. Learn more about Juneteenth from the National Museum of African American History and Culture: https://lnkd.in/gqvPZFF
Like Comment
To view or add a comment, sign in
REGENXBIO Inc.

31,928 followers
3w
Report this post
REGENXBIO announces successful pre-BLA meeting with FDA to support accelerated approval pathway for RGX-121 for the treatment of MPS II. Learn more: https://lnkd.in/ejDeH4Pi
9 Comments
Like Comment
To view or add a comment, sign in
REGENXBIO Inc.

31,928 followers
3w
Report this post
Last week, we were thrilled to welcome Dr. Kevin Flanigan to REGENXBIO. Dr. Flanigan is an esteemed researcher and leading expert in neuromuscular disorders, including Duchenne. Thank you, Dr. Flanigan, for sharing your insights and for your invaluable contributions to the Duchenne community!
2 Comments
Like Comment
To view or add a comment, sign in

31,928 followers

View Profile Follow

REGENXBIO Inc.’s Post

More Relevant Posts

Explore topics